Department of Discovery Chemistry, Bristol-Myers Squibb Pharmaceutical Research Institute, PO Box 4000, Princeton, NJ 08543-4000, USA.
Peptides. 2010 May;31(5):950-5. doi: 10.1016/j.peptides.2010.01.008. Epub 2010 Feb 4.
We report the identification of potent agonists of the Glucagon-Like Peptide-1 Receptor (GLP-1R). These compounds are short, 11 amino acid peptides containing several unnatural amino acids, including (in particular) analogs of homohomophenylalanine (hhPhe) at the C-terminal position. Typically the functional activity of the more potent peptides in this class is in the low picomolar range in an in vitro cAMP assay, with one example demonstrating excellent in vivo activity in an ob/ob mouse model of diabetes.
我们报告了胰高血糖素样肽-1 受体(GLP-1R)的有效激动剂的鉴定。这些化合物是短的 11 个氨基酸肽,包含几个非天然氨基酸,包括(特别是)在 C 末端位置的同型对羟苯丙氨酸(hhPhe)的类似物。通常,在体外 cAMP 测定中,此类更有效肽的功能活性在低皮摩尔范围内,有一个例子在肥胖/肥胖型糖尿病小鼠模型中显示出优异的体内活性。